Neuberger Berman Group’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.15M Buy
+541,155
New +$8.09M 0.01% 897

Other funds holding SMMT

Neuberger Berman Group's SMMT Position: Q3 2026 in Review

Neuberger Berman Group opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 541,155 shares worth $9.15M. The stake represents 0.01% of the portfolio and ranks #897 among its holdings.

294 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • Neuberger Berman Group held 541,155 shares of Summit Therapeutics worth $9.15M as of Q3 2026.
  • Summit Therapeutics was a new Neuberger Berman Group position in Q3 2026.
  • Summit Therapeutics made up 0.01% of Neuberger Berman Group's portfolio in Q3 2026, its #897 holding.
  • 294 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on Neuberger Berman Group's 13F filing for Q3 2026, filed 13 Nov 2026.